Noncompaction cardiomyopathy and stem cell therapy: from pathogenesis to targeted therapy?

Özeke, Özcan; Aras, Dursun; Tüfekçioğlu, Omaç; Aydoğdu, Sinan

doi:10.1080/14779072.2017.1256202

Expert Review of Cardiovascular Therapy

2016

DOI: 10.1080/14779072.2017.1256202

|View full text |Cite

Noncompaction cardiomyopathy and stem cell therapy: from pathogenesis to targeted therapy?

Özcan Özeke

Dursun Aras

Omaç Tüfekçioğlu

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2016

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Noncompaction cardiomyopathy and stem cell therapy: from pathogenesis to targeted therapy?

Cited by 1 publication

References 12 publications

Stem or progenitor cells for treating noncompaction?

Stem or progenitor cells for treating noncompaction?

Contact Info

Product

Resources

About